NeuroHarmonics
PrivateLast Round
Seed
Jan 22, 2026
Total Funding Raised
$2M
Company Overview
NeuroHarmonics is a deeptech company developing a non-invasive neurotechnology platform that uses ultrasound-based brain modulation to treat neurological and psychiatric conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroHarmonics Comparables
Compare NeuroHarmonics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SPIRE Therapeutics, Inc. | 89% | |
| Grey Matter Neurosciences | 87% | |
| Attune Neurosciences | 84% | |
NeuroHarmonics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 22, 2026 |
NeuroHarmonics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fusion Fund | Seed |
| EPSRC | Grant |
| Speedinvest | Seed |
| Jumpspace Ventures | Seed |
| Albion Capital | Seed |
| Wellcome Trust | Grant |
NeuroHarmonics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroHarmonics's valuation, stock price, and market status.